Building IP: BMY Patent Appl"CONTROL OF CELL GROWTH THROUGH A TEMPERATURE FEEDBACK... | BMY Message Board Posts


Bristol-Myers Squibb Co.

  BMY website

  • Please accept my sincerest apologies for failing to publicly acknowledge our fallen heroes this past Memorial Day. No excuse I could offer could justify the oversight. Along with you, I salute the many men and women who have proudly and selflessly served in our military to protect, defend and secure the freedoms and liberties we enjoy each and every day. Their bravery in making the ultimate sacrifice will forever be appreciated and they will always be remembered and celebrated and never taken for granted or forgotten.


BMY   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  10969 of 11272  at  3/23/2023 9:19:42 AM  by

JBWIN


Building IP: BMY Patent Appl"CONTROL OF CELL GROWTH THROUGH A TEMPERATURE FEEDBACK...

 

CONTROL OF CELL GROWTH THROUGH A TEMPERATURE FEEDBACK LOOP

DOCUMENT ID

US 20230090163 A1

DATE PUBLISHED

2023-03-23

INVENTOR INFORMATION

NAME

CITY

STATE

ZIP CODE

COUNTRY

ARON; Kathryn L.
Acton
MA
N/A
US
Swanberg; Jeffrey
Maynard
MA
N/A
US

APPLICANT INFORMATION

NAME
Bristol-Myers Squibb Company
CITY
Princeton
STATE
NJ
ZIP CODE
N/A
COUNTRY
US
AUTHORITY
N/A
TYPE
assignee

ASSIGNEE INFORMATION

NAME
Bristol-Myers Squibb Company
CITY
Princeton
STATE
NJ
ZIP CODE
N/A
COUNTRY
US
TYPE CODE
02

APPLICATION NO

18/053192

DATE FILED

2022-11-07

DOMESTIC PRIORITY (CONTINUITY DATA)

parent US continuation 16367837 20190328 ABANDONED child US 18053192

us-provisional-application US 62650430 20180330

US CLASS CURRENT:

1/1

CPC CURRENT

TYPE

CPC

DATE

CPCI
2013-01-01
CPCI
2013-01-01
CPCI
2013-01-01

Abstract

The present invention relates to the use of online biomass capacitance monitoring in cultures as a way to control the growth of cells through the use of a temperature control loop. In certain embodiments, a biomass capacitance probe is used to measure the cell density, and a predetermined growth curve is used to adjust the temperature in the culture.

Background/Summary

CROSS-REFERENCE TO RELATED APPLICATIONS

[0001] This application claims priority to U.S. Provisional Application No. 62/650,430, filed Mar. 30, 2018, which is incorporated herein by reference in its entirety.

BACKGROUND OF THE INVENTION

[0002] Understanding cell growth is critical for developing efficient and robust bioreactor processes. Due to exponential growth characteristics, small perturbations in process conditions such as inoculation density, media composition, and pH can have large impacts on cell density and process performance. In addition standard offline measurement techniques fail to capture important data such as the exact cell peak time and density. This can make cell density based process decisions such as temperature shifting difficult to time.

[0003] There is a need in the art for mechanisms to dynamically adjust cell growth to precisely control the timing of cell growth from inoculation to peak.

SUMMARY OF THE INVENTION

[0004] In some embodiments, the invention is directed to a method of controlling the growth of cells in a bioreactor comprising: a) measuring the viable cell density of the cells growing in culture using a biomass capacitance probe; and b) utilizing a temperature control loop to adjust the growth rate of the cells.

[0005] In certain embodiments, the invention is directed to a method of modulating reactor temperature to control the growth of cells in a bioreactor comprising: a) measuring the viable cell density of the cells growing in culture using a biomass capacitance probe; and b) utilizing a temperature control loop to modulate the reactor temperature and adjust the growth rate of the cells.

[0006] In embodiments, the invention is directed to a method of minimizing the growth fluctuation of cells in a bioreactor comprising: a) measuring the viable cell density of cells growing in culture using a biomass capacitance probe; and b) utilizing a temperature control loop to adjust the growth rate of the cells.

[0007] In some embodiments, a pre-determined growth curve is utilized to adjust the temperature in the culture.

[0008] In embodiments, a bolus feed is added to the bioreactor daily. In certain embodiments, the daily bolus feed is begun starting on about day 1, about day 1.5, about day 2, about day 2.5, about day 3, about day 3.5, about day 4, about day 5, about day 6, about day 7, about day 8, about day 9 or about day 10 after the culture is inoculated. In particular embodiments, the daily bolus feed volume is about 1%, about 2%, about 3%, about 4%, about 5%, about 6%, about 7%, about 8%, about 9%, about 10%, about 15% or more of the initial working volume. In some embodiments, the daily bolus feed volume is about 3%, about 3.1%, about 3.2%, about 3.3%, about 3.4%, about 3.5%, about 3.6%, about 3.7%, about 3.8, about 3.9% or about 4% of the initial working volume. In one embodiment, the daily bolus feed volume is about 3.6% of the initial working volume.

[0009] In embodiments, a bolus feed is added to the bioreactor hourly. In certain embodiments, the hourly bolus feed is begun starting on about day 1, about day 1.5, about day 2, about day 2.5, about day 3, about day 3.5, about day 4, about day 5, about day 6, about day 7, about day 8, about day 9 or about day 10 after the culture is inoculated. In an embodiment, the hourly bolus feed is about 1/24 of the calculated volume for a daily bolus feed. In one embodiment, the hourly bolus feed is about 0.1%, about 0.11%, about 0.12%, about 0.13%, about 0.14%, about 0.15%, about 0.16%, about 0.17%, about 0.18%, about 0.19%, about 0.2%, about 0.25%, about 0.3%, about 0.4% or about 0.5% of the initial working volume. In particular embodiments, the hourly bolus feed volume is about 0.15% of the initial working volume.

[0010] In some embodiments, the viable cell density is plotted to a temperature range of about 30-40° C. In certain embodiments, the viable cell density is plotted to a temperature range of about 31-37° C. In embodiments, daily temperature oscillations in the reactor have a peak to peak amplitude of about 10° C., about 9° C., about 8° C., about 7° C., about 6° C., about 5° C., about 4° C., about 3° C., about 2° C., about 1° C. or less.

[0011] In embodiments, the cells produce a polypeptide of interest. In certain embodiments, the polypeptide of interest is an antibody. In some embodiments, the cells are mammalian cells. In particular embodiments, the cells are CHO cells.

[0012] In embodiments, the biomass capacitance probe is an INCYTE probe.

[0013] In some embodiments, the pH of the culture is about 6.5 to about 8.0, about 7.0 to about 8.0, or about 7.0 to about 7.5. In particular embodiments, the pH of the culture is about 7.1 to about 7.4.

[0014] In embodiments, the culture is inoculated with cells at a density of about 1×10.sup.5, about 2×10.sup.5, about 3×10.sup.5, about 4×10.sup.5, about 5×10.sup.5, about 6×10.sup.5, about 7×10.sup.5, about 8×10.sup.5, about 9×10.sup.5, or about 10×10.sup.5 cells/ml. In particular embodiments, the culture is inoculated with cells at a density of about 6×10.sup.5 cells/ml.



     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 0  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board




Financial Market Data provided by
.
Loading...